As Apple ramped up Mac chip investments, improvements to its other chips slowed down; sources say Apple Watch Series 8 might be able to detect a fever in users
When it comes to Apple's chip advancements, the company's iPhone and watch are taking a back seat to the Mac.
Context & Ripple Effects
Apple’s Mac chip push followed the planned launch of Apple Silicon Macs, while a holiday-period chip shortage underscored the constraints around device components. The reported shift makes Apple’s processor roadmap a trade-off across its own product lines, not simply a uniform annual upgrade cycle.
Subsequent coverage aligned with that pattern: the Watch S8 was reported to use the same CPU as prior models, before Apple later introduced the faster S9 chip.
First-order effects
- Apple’s iPhone and Apple Watch teams face slower chip improvements as Mac silicon receives more investment, while a possible Series 8 fever-detection feature gives the Watch a non-CPU upgrade point.
- Mac development receives the immediate benefit of Apple’s chip-engineering priority during its transition to Apple Silicon.
Second-order effects
- Apple Watch upgrade messaging shifts toward health sensing when processor gains are limited; the later unchanged S8 CPU report illustrates that constraint.
- Component shortages make internal allocation more consequential, because Apple cannot assume every product line can advance its chips at the same pace.
Third-order effects
- If Apple maintains product-specific chip prioritization, its hardware cycles will increasingly be defined by which device category receives the next silicon leap rather than synchronized upgrades across Mac, iPhone, and Watch.
- Health sensors can become a parallel upgrade path for wearables when compute-roadmap resources are concentrated on another device category.
The trend: Apple’s in-house silicon strategy is creating differentiated upgrade cadences across its device portfolio, with Mac transition work temporarily taking precedence over iPhone and Watch performance gains.